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Abstract The purpose of this study was to determine if
diVerent body habitus, including prostate weight, body
mass index (BMI) and height, are associated with surgical
outcomes in patients undergoing robot-assisted laparo-
scopic radical prostatectomy (RLRP). Between July 2005
and June 2007, 135 patients underwent RLRP by a single
surgeon. Information was collected retrospectively on
prostate weight, BMI and height. Surgical outcome was
assessed by total operative time, estimated blood loss
(EBL) and surgical margin as parameters of technical diY-
culty. When statistically analyzed, prostate size was signiW-
cantly related to total operative time (P = 0.001) and EBL
(P = 0.033). But prostate size was not signiWcantly related
to the surgical margin. Patient BMI and height did not
appear to aVect surgical outcomes. Despite a shift in body
frames towards the western standard, most Asians still have
shorter stature, lower BMI and smaller prostates. We have
found from our experience that diVerent body habitus is not
signiWcantly related to surgical outcomes of RLRP, and
therefore, it seems promising to operate successfully on
Asian patients. However, it is important to obtain long-term
outcomes on a larger cohort of patients in order to conWrm
our Wndings.
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Introduction
Recent medical advances have made a signiWcant change of
scene in operating rooms. Laparoscopic radical prostatectomy
(LRP), which was introduced only just over a decade ago, was
thought to be an eVective method of controlling prostate can-
cer, but it still had technical diYculties [1]. Surgeon’s 2D
vision and rigid instrumental movements limited the surgical
Weld, especially in patients with physical variation [2]. Now
robot-assisted laparoscopic radical prostatectomy (RLRP) is
an emerging surgical option for patients with prostate cancer.
RLRP is an innovative version of LRP. Since the intro-
duction of RLRP a few years ago, a number of studies have
shown that its minimally invasive approach has overcome
the technical challenges faced by LRP, although less is
known about its patient feasibility [3, 4]. Advantages of
RLRP became especially valuable in more complicated
cases such as operating on obese patients [5–7].
Recent reports claim that the technical diYculties result-
ing from physical variation have been overcome, but at this
stage, it remains controversial. Most Asians have shorter
stature, lower BMI and smaller prostates [8, 9]. These
diVerences from the western population may lead to varied
surgical outcomes of RLRP. The objective of this study is
to assess the hypothesis that the size of the prostate, obesity
and height inXuence surgical outcomes. Our research
focuses on Korean patients undergoing RLRP, and we hope
this study will contribute towards the expanding Weld of
RLRP among the Asian population.
Materials and methods
Between July 2005 and June 2007, 135 patients underwent
RLRP by a single surgeon. This was a non-randomized,
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we did not limit surgical candidacy by previous surgical
history or body habitus. Information was recorded using
patient charts retrospectively on prostate weight, body mass
index (BMI) and height. Technical diYculties and overall
surgical outcomes were assessed based on total operative
time, estimated blood loss (EBL) and surgical margin sta-
tus. In all cases, at least two of three data sources were
reviewed.
Patients were divided into three groups according to
their pathologic prostate weight. Patients were classiWed as
having a small prostate if it weighed less than 30 g (group
1), normal between 30 and 50 g (group 2) and large if
greater than 50 g (group 3).
The World Health Organization describes BMI as a sim-
ple index of weight for height that is commonly used to
classify underweight, overweight and obese adults. It is
deWned as the weight in kilograms divided by the square of
the height in meters (kg/m2). However, the values are based
on western populations, and it may not be exactly suitable
to use in Asians. Therefore, we used a diVerent BMI scale
speciWcally designed to be applicable to Asian males that
was announced recently. The current WHO ClassiWcation
of BMI states that patients over 25 kg/m are considered
overweight [8]. In our study, we used 23 kg/m2 instead as
the cutoV point, which was introduced by WHO experts.
Patients were considered to be of normal weight with a
BMI greater than 23 kg/m2 (group 1), overweight with
greater than 23 kg/m2 but less than 27.5 kg/m2 (group 2),
and obese with 27.5 kg/m2 or greater (group 3).
Individuals were considered to be of short stature (group
1) if their height was equal to or less than the Wrst lower
quartile of the height distribution of the population of the
same gender. Individuals whose heights fell in the second
and third quartiles were classiWed as being of normal or
average stature (group 2). Individuals above the third quar-
tile were classiWed as tall (group 3) [10]. Statistical values of
height were obtained from the Korea National Statistical
OYce. The average height of Korean males above the age of
60 was 161 cm [11]. Patients below 161 cm were classiWed
as being short (group 1), between 161 and 168 cm as being
average height (group 2), and tall (group 3) above 168 cm.
Surgical outcome was assessed by total operative time,
EBL and surgical margin as parameters of technical diY-
culty. Total operative time was deWned as the time between
the start of Veress needle insertion and skin closure includ-
ing the time spent for robot preparation and docking [12].
The attending anesthesiologist recorded EBL during sur-
gery based on the amount of Xuid collected by the suction
device. Surgical margin status was divided into positive or
negative.
RLRP was performed using the da Vinci Robotic
System™ (Intuitive Surgical, Mountain View, CA). Our
surgical technique was based on Vattikuti Institute Prosta-
tectomy with slight modiWcation [13].
Statistical evaluation was made using SPSS, and com-
parative analysis was done using Spearman correlation
coeYcient and ANOVA, with P < 0.05 considered as statis-
tically signiWcant.
Results
The mean age and preoperative prostate-speciWc antigen
(PSA) of 135 patients undergoing RLRP were 64 and
8.0 ng/ml, respectively. The mean BMI, prostate weight
and height of 135 patients were 24.3 kg/m2, 5.5 g and
169 cm, respectively. The mean operative time was
220 min (range 149–418). Total operative time was sig-
niWcantly related to prostate weight (P = 0.001). It
appeared from statistical analysis that heavier prostate
weight was signiWcantly related to longer operative time.
BMI and height did not signiWcantly aVect total operative
time. The mean EBL was 413 ml (range 50–2,700). The
EBL was not signiWcantly related to BMI or height. When
compared within diVerent prostate weight groups, EBL
was not signiWcantly related to prostate weight (P = 0.329).
However, a signiWcant positive relationship was found
between prostate weight and EBL when diVerent parame-
ters were compared (P = 0.033). The positive margin rate
was present in 41 cases out of a total of 135 patients.
Margin status was not signiWcantly related to surgical out-
comes either within groups or between parameters. The
relationship between surgical outcomes and each variable
is shown in Table 1.
Discussion
Soon after Schuessler et al. [1] Wrst attempted LRP in 1992,
massive worldwide interest in minimally invasive surgery
was initiated, and many drawbacks of open prostatectomy
were overcome [14]. However, reduced tactile feedback
and inability of the surgeon to control the view of the surgi-
cal Welds and two-dimensional vision remained as potential
disadvantages of LRP [2, 15].
Extensive studies have been done to investigate relation-
ship between patient body habitus and perioperative com-
plications in LRP patients. This has been reported by other
LRP series using diVerent techniques [16–19]. Chang et al.
[20] reported signiWcantly longer operative times for 400
patients undergoing LRP within larger prostate weight
groups. However, Boczko et al. [21] described that the only
signiWcant diVerence in operative parameters of RLRP was
a small increase in blood loss in patients with large prostate
size. No impact was seen on total positive margin status123
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the operative parameters aVected by increasing prostate
size were operative times and EBL. Surgical margin status
was not inXuenced by varying prostate size.
LRP is no diVerent from other operations in that thin
patients are normally easier to operate on compared to
obese patients [17, 22]. Whether or not this has an eVect on
perioperative outcomes is not clear.
Not long after the development of LRP, Binder and
Kramer [23] performed the Wrst RLRP at Frankfurt Univer-
sity using the Da Vinci System™ in May 2000. RLRP is
more favorable compared to LRP in that it has a more grad-
ual learning curve. Technical factors of RLRP that may
direct towards a favorable position include 3D vision of the
surgical Weld, increased degrees of free movement and
Wltered hand tremor. While RLRP appears to be an eVective
surgical option for prostatectomy, lack of dexterity remains
a major disadvantage. Other obstacles to be overcome
include its high cost and the bulky machinery itself [2, 4,
15, 24]. With regard to RLRP and patient outcomes, the
current data available are not completely mature. Neverthe-
less, it has been suggested that body habitus may lead to a
less favorable outcome. Hemal et al. [25] emphasize that
subtle adjustments to standard port placement are required
for patient consideration and optimal surgical results.
Ahlering et al. [26] reported on their results comparing
patients undergoing RLRP classiWed by their BMI (over
30 kg/m as obese). Greater blood loss and longer operative
time were noted in 19 obese patients than in 81 who were
not obese. Obese patients may require longer instruments.
However, in a recent study done by Zorn et al. [19] diVer-
ences in prostate weight did not aVect surgical outcomes of
RLRP signiWcantly.
Despite its unknown feasibility, RLRP has been adapted
by medical centers worldwide since its Wrst trial. In Korea,
the Wrst RLRP was performed and documented by Lee et al.
[27]. Prostate cancer is a relatively less common type of
cancer in Korea compared to western countries. Among
men over the age of 65 years, it is the Wfth most common
cancer. However, despite its low rates, a recent study done
by Park et al. [28] showed a trend of increasing incidences
of prostate cancer in most parts of Korea. Although no clear
explanation has been made, factors including fast westerni-
zation and change in diet, such as increased meat and fat
intake, are linked to elevated prostate cancer risk. It is
therefore crucial to have a structured understanding of the
disease and its eVective treatment speciWc to Koreans.
Although we have not encountered any major complica-
tions due to diVerent body habitus among patients, it must
be emphasized that the present technique of RLRP is
designed to suit western physiques.
Conclusion
A review of the published MEDLINE literature is currently
insuYcient to determine the surgical feasibility of RLRP in
the Asian population. Despite a shift in body frame towards
western standards, most Asians still have shorter stature,
lower BMI and smaller prostates. We have found from our
experience that diVerent body habitus is not signiWcantly
related to surgical outcomes of RLRP, and therefore it
seems promising to operate successfully on the Asian popu-
lation. However, if the trend of westernization is to be con-
tinued, diVerent consequences may follow. It is therefore
important to obtain long-term outcomes on a larger cohort
of patients in order to conWrm our Wndings. Furthermore, it
must be emphasized that the data used in this study are non-
randomized and intra-institutional. Caution must be taken
when interpreting the results and understanding their limits.
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